Microcyn Technology, an anti-infective therapeutic with wound healing
capability, is a small molecule oxychlorine compound that mimics the same
oxychlorine composition as that manufactured by neutrophils in the body’s immune system. Neutrophils are the most abundant type of
white blood cells in humans and form an integral part of the immune system. One
of Microcyn’s primary modes of action is its ability to
treat a wide range of pathogens, including antibiotic-resistant strains of
bacteria (including MRSA and VRE), viruses, fungi and spores. Studies also
demonstrate that Microcyn delivers wound-healing benefits including increased
blood flow to the wound bed and reduction of inflammation all while remaining
safe as saline and biocompatible. Microcyn Technology is novel in that it has
antimicrobial and wound healing properties in a uniquely stable formulation.
Bruce Thornton, vice president of international sales and operations for
Oculus Innovative Sciences, said, “Our marketing and
clinical teams continuously solicit market feedback and one of the most frequent
requests has been for a Microcyn gel formulation that encapsulates both the
safety profile and the efficacy of the original Microcyn solution in an
extended-moistening formula that also provides an ongoing barrier to infection
and a medium that allows for delivery of Microcyn’s
active ingredients over an extended period of time. The R&D team has created
a large U.S. and international opportunity with this Microcyn-Gel and we look
forward to moving rapidly to bring this product to commercialization, first in
our existing distribution channels in India, Europe, Mexico, China, and then in
the U.S. upon 510k clearance from the FDA.”
About Oculus Innovative Sciences
Oculus Innovative Sciences is a biopharmaceutical company that develops,
manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to help prevent and
treat infections in chronic and acute wounds. The Microcyn Technology platform
is a biocompatible, shelf-stable solution containing active oxychlorine
compounds that is currently commercialized outside the United States (Europe,
India and Mexico) for the treatment of infected wounds. The solutions derived
from the Microcyn Technology platform have demonstrated, in a variety of
research and investigational studies, the ability to treat a wide range of
pathogens, including antibiotic-resistant strains of bacteria (including MRSA
and VRE), viruses, fungi and spores.
In addition to the company’s existing and
under-development therapeutic products, Oculus also develops, manufactures and
markets a number of 510k devices and products for both professional and
consumer. This includes the recently announced Oculus MDD (Microcyn Delivery
Device) for dressing-free treatment of both chronic and acute wounds. As well,
Dermacyn Wound Care is currently being test marketed in the U.S. for the
moistening and debriding of wounds.
A recently completed U.S. Phase II clinical trial of Microcyn Technology met
the primary endpoints of safety and efficacy for the treatment of mildly
infected diabetic foot ulcers.
Oculus' principal operations are in Petaluma, California, and it conducts
operations in Europe, Latin America and Japan through its wholly owned
subsidiaries, Oculus Innovative Sciences Netherlands B.V., Oculus Technologies
of Mexico, S.A. de C.V. and Oculus Japan K.K. Oculus' website is www.oculusis.com.
Could a grave danger be lurking in your home? If you believe the headlines, you know that catching the Superbug can have deadly consequences, but should you be concerned? How can you spot the danger, and what can you do to stay safe? Dr. Phil gets to the bottom of these questions and others. Melissa's son, Mark, was just 13 when he went to the hospital and wound up with MRSA, also known as the Superbug. Learn about Melissa’s tragic loss and why she thinks her son’s death could have been prevented. Then, 19-year-old Stephanie has been battling the Superbug for almost a year. Get a firsthand account of her experience with the disease, and find out what advice her doctor gave her that has Dr. Phil shocked and concerned. Even doctors aren’t immune to the Superbug. Dr. Drew O’Neal had an accident while on vacation, and what happened next changed his life forever. He shares his valuable insights as both doctor and patient. Plus, two years ago, Glen was your average sophomore playing on his high school football team -- until he contracted the Superbug right from the team’s locker room. Find out what important lessons he learned that could help protect you and your children from the disease. And renowned pediatrician Dr. Jim Sears weighs in with the latest information and shows off products to keep on hand that could save your life. Join the discussion.
